Divozilimab (Anti-CD20)
Divozilimab (Anti-CD20) (A2823-GRP)
Products
Description
Divozilimab (BCD-132) is a humanised monoclonal antibody against CD20 (CD20) with the potential to be used in multiple sclerosis research. MW : 145.26 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2823 |
| Target | CD markers |